2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …

N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Atrial fibrillation and dementia: a report from the AF-SCREEN international collaboration

L Rivard, L Friberg, D Conen, JS Healey, T Berge… - Circulation, 2022 - Am Heart Assoc
Growing evidence suggests a consistent association between atrial fibrillation (AF) and
cognitive impairment and dementia that is independent of clinical stroke. This report from the …

Atrial fibrillation and stroke: A review and new insights

I Escudero-Martinez, L Morales-Caba… - Trends in Cardiovascular …, 2023 - Elsevier
The link between heart and brain continues to be a matter of great interest for the scientific
community. One of the most established associations between the two is that the heart is a …

Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study

M Anjum, I Ariansen, V Hjellvik, R Selmer… - European heart …, 2024 - academic.oup.com
Abstract Background and Aims The benefit of oral anticoagulant (OAC) therapy in atrial
fibrillation (AF) and intermediate stroke risk is debated. In a nationwide Norwegian cohort …

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal

DA Lane, GYH Lip - European Heart Journal Supplements, 2020 - academic.oup.com
Atrial fibrillation (AF) significantly increases the risk of stroke and, therefore, stroke
prevention is an essential component of the management for patients with AF. This requires …

Matrix metalloproteinases in Cardioembolic stroke: from background to complications

A Wysocka, J Szczygielski, M Kopańska… - International Journal of …, 2023 - mdpi.com
Matrix metalloproteinases (MMPs) are endopeptidases participating in physiological
processes of the brain, maintaining the blood–brain barrier integrity and playing a critical …

Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation

VHW van der Endt, J Milders, BBL Penning de Vries… - Europace, 2022 - academic.oup.com
Aims Multiple risk scores to predict ischaemic stroke (IS) in patients with atrial fibrillation (AF)
have been developed. This study aims to systematically review these scores, their …

Connections between Cognitive Impairment and Atrial Fibrillation in Patients with Diabetes Mellitus Type 2

M Militaru, DF Lighezan, C Tudoran, AG Militaru - Biomedicines, 2024 - mdpi.com
(1) Background: Cognitive decline (CD), considered a precursory state of dementia, is
frequently encountered in patients with diabetes mellitus type 2 (DM-2) and might even have …